<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fba/5667418/6b510127a477/thnov07p3962g006.jpg"/> </div> <div class="text-side"> <h1>Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma.</h1> <p> Histological characterization 24 days post treatments. Representative images of tumor sections and adjacent tissue are presented. Shown are saline administration (no treatment, A-A''''), radiation only (B-B''''), crizotinib-GNP (C-C''''), crizotinib-radiation (D-D'''') and radiation-crizotinib-GNP (E-E''''). Sections were stained with H&amp;E (A-E), Ki-67 (A'-E', brown); TUNEL (A''-E'', green), PCNA (A'''-E''', green) ALK (A''''-E'''', red) and CD34 (red). Rx= radiation. Bar = 100 Âµm. Immunostaining intensity was analyzed using LSM software.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29109791/" target="_blank">29109791</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>